Earnings Call Insights: Willis Towers Watson (WTW) Q4 2025 Management View CEO Carl A. Hess stated that "we closed the year with another strong quarter, driven by our focused strategy and a steady execution by all our WTW colleagues," emphasizing the company's strategic efforts to accelerate performance, enhance efficiency, and optimize the portfolio. Hess highlighted the divestiture of TRANZACT and acquisitions of Newfront, Cushon, and FlowStone Partners as key moves to strengthen WTW's business mix and profitability. He noted, "we generated 6% organic growth, 80 basis points of adjusted operating margin expansion and adjusted EPS of $8.12" for the quarter. Hess detailed that Risk & Broking achieved 7% organic growth, with Corporate Risk & Broking marking its 12th consecutive quarter of high single-digit growth. He underscored wins in digital infrastructure, including support for "5 of the 10 largest data center developers globally," and a high-profile appointment as insurance broker for two major U.S. bank headquarter renovation projects. In Health, Wealth & Career, organic growth accelerated to 6% with notable client wins across geographies and expanding LifeSight assets under management by GBP 400 billion from a Fortune 50 technology client. Hess announced the closure of the Newfront acquisition, stating, "Newfront brings a modern technology-enabled approach to middle market broking, combining deep specialty expertise with a proprietary digital and AI-driven platform." Integration is set to be a key focus for 2026, with a dedicated management office established. CFO Andrew Krasner stated, "In the fourth quarter, we delivered solid organic revenue growth of 6% and expanded adjusted operating margin by 80 basis points year-over-year to 36.9% or 30 basis points of year-over-year improvement when excluding TRANZACT. Adjusted diluted earnings per share were $8.12, which is an increase of 13% over the prior year when excluding TRANZACT." Krasner attributed margin expa...

文章提及标的 原油 -- 沪金主力合约 -- 沪银主力合约 -- 上期所原油期货夜盘收涨1.78%，报457.8元/桶。沪金主力合约收涨4.20%，报1109元/克，沪银主力合约收涨5.93%，报22393元/千克。

SanDisk (SNDK) stock just got one of the most aggressive votes of confidence on Wall Street. Bernstein SocGen Group analyst Mark C. Newman just dropped a jaw-dropping new price target of $1,000 on the memory chip players' stock while keeping an outperform rating. The new target represents a 72.4% ...

Friedenthal Financial disclosed a buy of 89,706 shares of First Trust Low Duration Opportunities ETF (NASDAQ:LMBS) in its Jan. 27, 2026, SEC filing, with an estimated transaction value of $4.48 million based on quarterly average pricing. According to a Jan. 27, 2026, SEC filing , Friedenthal Financial bought 89,706 shares of First Trust Low Duration Opportunities ETF, an estimated $4.48 million trade based on the average share price during the quarter. As a result, the stake’s value at quarter-end rose by approximately $4.50 million, inclusive of both the new shares and market price changes. First Trust Low Duration Opportunities ETF (LMBS) is a large, actively managed ETF with a market capitalization of $5.73 billion. The fund seeks to deliver current income and capital preservation by investing predominantly in mortgage-related securities, balancing risk through active portfolio management. Its strategy targets investors seeking a stable income stream and reduced interest rate sensitivity compared to longer-duration bond funds. Continue reading

白宫称美国与伊朗的会谈仍将按计划进行 2026-02-04 02:32:41 来源： 同花顺7x24快讯 分享 总台记者当地时间2月3日获悉，白宫方面表示，本周晚些时候与伊朗的会谈仍将按计划进行。当天稍早前，有知情人士透露，伊朗希望将原定于6日与美国举行的会谈从土耳其伊斯坦布尔移至阿曼，并以双边形式举行。目前伊朗方面尚未就此作出回应。(央视新闻)

Jurors were told on Tuesday by Hames that he was not able to confirm a distance between the aunts and Xielo at the moment he fell into the water due to the "limitations" of the CCTV from where the camera is situated.

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo

Economists have expressed surprise and disappointment about the absence of any public remarks, which had been a routine part of the Fed nomination process going back almost 30 years.

The AI revolution has broken a 60-year-old rule. Since early November, fears of overvaluation have dragged on tech stocks. As major investment banks warned of possible corrections, the tech-heavy Nasdaq Composite (^IXIC 2.11%) has been volatile while also relatively flat since October 2025. In the three months since, it's gone from 23,348 to 23,461 -- a gain of less than half a percent. Meanwhile, Microsoft's 10% share price plunge after the release if its Jan. 28 earnings report, despite growing profits by 60% year over year, shows how high expectations for tech companies have become in the age of artificial intelligence (AI). Expand NASDAQINDEX : ^IXIC NASDAQ Composite Index Today's Change ( -2.11 %) $ -496.80 Current Price $ 23095.31 Key Data Points Day's Range $ 23091.91 - $ 23691.60 52wk Range $ 15267.91 - $ 23958.47 For anyone old enough to remember the dot-com collapse, the nervousness is understandable. In March 2000, the Nasdaq began what became a years-long sell-off that fell as much as 77%, with then tech darlings like Cisco Systems (CSCO +2.18%), Intel, and Oracle collapsing by even more. When a stock falls by 80%, it doesn't need an 80% rebound to break even; it needs a 400% gain. Buying on the eve of a bubble's collapse can wreck investors -- at least those without risk management strategies such as stop-loss orders in place -- so it's understandable how, with the tech rally now in its fourth year, overvaluation fears are front and center. The fear is acute enough that Jensen Huang, the CEO of semiconductor giant Nvidia (NVDA 3.66%), the world's largest company by market capitalization and poster child for the $15.7 trillion AI revolution, addressed rumors of a bubble in Nvidia's most recent earnings presentation in mid-November. Nvidia's CEO: "We see something very different" According to Huang, the technological principle Moore's Law, the observation that microchips and semiconductors become twice as powerful every 18 months or so, has been shattered...

Key Points With the tech rally now in its fourth year, overvaluation fears are top of mind to many investors. History shows that investing before a bubble's collapse can lead to losses of 77% or even higher. Looking at the collapse of the last major tech bubble, there are two key differences with AI stocks today. 10 stocks we like better than NASDAQ Composite Index › Since early November, fears of overvaluation have dragged on tech stocks. As major investment banks warned of possible corrections, the tech-heavy Nasdaq Composite (NASDAQINDEX: ^IXIC) has been volatile while also relatively flat since October 2025. In the three months since, it's gone from 23,348 to 23,461 -- a gain of less than half a percent. Meanwhile, Microsoft's 10% share price plunge after the release if its Jan. 28 earnings report, despite growing profits by 60% year over year, shows how high expectations for tech companies have become in the age of artificial intelligence (AI). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » For anyone old enough to remember the dot-com collapse, the nervousness is understandable. In March 2000, the Nasdaq began what became a years-long sell-off that fell as much as 77%, with then tech darlings like Cisco Systems (NASDAQ: CSCO), Intel, and Oracle collapsing by even more. When a stock falls by 80%, it doesn't need an 80% rebound to break even; it needs a 400% gain. Buying on the eve of a bubble's collapse can wreck investors -- at least those without risk management strategies such as stop-loss orders in place -- so it's understandable how, with the tech rally now in its fourth year, overvaluation fears are front and center. The fear is acute enough that Jensen Huang, the CEO of semiconductor giant Nvidia (NASDAQ: NVDA), the world's largest company by market capitalization and poster child for the $15.7 trillion AI revolution, addressed rumors of a bubble in Nvidia's most rece...

格隆汇2月4日｜据沙特国家通讯社：沙特与土耳其签署可再生能源项目协议。

Eight of them were the relatives of Awad Abu Talha. He had waited for his cousins all day and evening as they progressed slowly through the crossing. Some had made it through to the Palestinian side, before all were sent back to Egypt, because of a technical problem.

Earnings Call Insights: Merck & Co., Inc. (MRK) Q4 2025 Management View Chairman and CEO Robert Davis emphasized the company's portfolio transformation, highlighting, "In 2025, our business benefited from successful new product launches, the advancement of important clinical programs and the expansion of our respiratory and infectious disease portfolios through the acquisitions of Verona Pharma and Cidara Therapeutics." Davis stated that Merck now sees a "line of sight to over $70 billion of potential commercial opportunity by the mid-2030s, $20 billion more than just a year ago and more than double consensus 2028 peak KEYTRUDA revenue of $35 billion." He added, "This meaningful progress further bolsters my already high confidence in our ability to deliver sustainable growth post the KEYTRUDA LOE period." Davis detailed upcoming clinical milestones, including first-time Phase III data for several novel candidates in 2026, and noted, "Ten of these programs could be substantially clinically derisked over the next 2 years and represent the majority of our $70 billion of non-risk-adjusted commercial opportunity by the mid-2030s." CFO Caroline Litchfield reported, "Total company revenues were $16.4 billion, an increase of 5% or 4% excluding the impact of foreign exchange." Litchfield highlighted "continued strength in oncology and Animal Health as well as increasing contributions from new product launches," and confirmed, "Earnings per share were $2.04." Executive VP and President of Merck Research Laboratories Dean Li announced, "Enlicitide, our investigational oral PCSK9 inhibitor has been designed to deliver antibody-like efficacy while offering a simple once-daily oral treatment option." Li also noted progress for WINREVAIR and the advancement of the Cidara acquisition, stating, "MK-1406, formerly CD388 is a potentially first-in-class long-acting antiviral candidate designed to help prevent influenza infection." Li projected that "MK-1406 has greater than $5 billion ...

Earnings Call Insights: Illinois Tool Works Inc. (ITW) Q4 2025 Management View CEO Christopher O'Herlihy highlighted, "ITW delivered a solid finish to the year. In the fourth quarter, we outperformed our underlying end markets with revenue growth of more than 4% and delivered a 7% increase in GAAP EPS to $2.72." He emphasized operating income of $1.1 billion, a 5% increase, and record segment margins of 27.7%, up 120 basis points, with enterprise initiatives contributing 140 basis points. O'Herlihy stated, "We are pleased to have achieved 2.4% CBI fueled revenue growth in 2025, a 40 basis point improvement as we track toward our 2030 goal of 3% plus." Patent filings, a key CBI metric, increased by 9% in 2025. Looking forward, "Our organic growth projection of 1% to 3% reflects current demand levels adjusted for seasonality. Our EPS guidance midpoint of $11.20 represents 7% growth, and we expect operating margin expansion of about 100 basis points powered by enterprise initiatives." CFO Michael Larsen reported, "Organic growth was 1.3%. Foreign currency translation added 2.5% and acquisitions contributed 0.3%, bringing total revenue growth to 4.1%." He noted, "We achieved a fourth quarter record operating margin of 26.5%, with enterprise initiatives contributing 140 basis points. Segment operating margin was 27.7%, a 120 basis point increase with incremental margins of more than 50%." Free cash flow conversion to net income was 109% and the company repurchased $375 million in shares. Outlook Larsen provided 2026 guidance: "Our total revenue projection of 2% to 4% and organic growth projection of 1% to 3% is based on current levels of demand adjusted for typical seasonality." The company projects GAAP EPS in a range of $11 to $11.40, with the midpoint representing 7% growth. Operating margin is expected to improve by approximately 100 basis points to a range of 26.5% to 27.5%. Free cash flow conversion to net income is forecast at greater than 100%, with $1.5 billion ...

利弗莫尔中概股龙头指数跌幅扩大至2.4%，成分股中，哔哩哔哩、金山云跌近5%，阿里巴巴跌超4%。 免责声明： 风险提示：本文内容仅供参考，不代表同花顺观点。同花顺各类信息服务基于人工智能算法，如有出入请以证监会指定上市公司信息披露平台为准。如有投资者据此操作，风险自担，同花顺对此不承担任何责任。

Earnings Call Insights: Hubbell Incorporated (HUBB) Q4 2025 Management View Gerben Bakker, President, CEO & Chairman, stated that "Hubbell delivered strong financial results in the fourth quarter, highlighted by 12% total sales growth, 140 basis points of adjusted operating margin expansion, 19% adjusted operating profit growth and 15% adjusted earnings per share growth." He emphasized 9% organic growth in the quarter, driven by double-digit organic gains in Electrical Solutions and Grid Infrastructure. Bakker highlighted robust demand from data center build-outs, load growth, and grid resiliency investments, positioning Hubbell at the intersection of grid modernization and electrification megatrends. Bakker pointed to significant progress in unifying the Electrical Solutions segment and above-market growth in focused verticals, noting "7% organic growth and 14% adjusted operating profit growth for the full year," with margins exceeding 20% for the first time in the segment's history. Within Utility Solutions, strong performance in Grid Infrastructure was contrasted by softness in metering and AMI, but over 80% of the portfolio remains aligned with electric T&D components. Bakker reported the acquisition of DMC Power, automation investments, production capacity expansions, and innovative product launches as key 2025 accomplishments. Joseph Capozzoli, Senior VP & CFO, said, "Net sales of $1.493 billion in the fourth quarter of 2025 increased by 12% as compared to the prior year, driven by 9% organic growth and acquisitions contributing 3%." Capozzoli added, "We generated $349 million of adjusted operating profit and expanded adjusted operating margins by 140 basis points in the fourth quarter," highlighting strong price realization and productivity actions offsetting cost inflation. Outlook Hubbell projects "5% to 7% organic growth across our portfolio in 2026," with Utility Solutions expected to deliver 5% to 7% organic growth and Electrical Solutions 4% to 6%. Bakk...

Earnings Call Insights: Ashland Inc. (ASH) Q1 2026 Management View CEO Guillermo Novo highlighted that "we delivered solid results, while navigating ongoing demand softness in coatings and constructions, supported by strong execution and disciplined cost actions." Novo emphasized Life Science's healthy growth, with injectables, tablet coatings, and high-value cellulose excipients contributing to year-over-year gains. He noted, "Personal Care delivered stable performance with underlying demand broadly steady," while acknowledging that "Specialty Additives continued to face muted demand with coatings and construction driving most of the year-over-year decline." Novo also addressed operational challenges, stating, "the impact we expected to be contained within the first quarter will now extend into the second quarter" regarding equipment issues at the Calvert City unit. He added that recent weather-related events in the Mid-Atlantic region would lead to incremental costs. CFO William Whitaker stated, "Our first quarter performance reflects increasing consistency of our operating model. Across the portfolio, the team executed well, advanced our initiatives and managed through operational impacts, while maintaining solid cost discipline." He added, "Sales for the quarter were $386 million, down 5% versus last year," and confirmed that adjusted EBITDA was $58 million, down 5% year-over-year, with a $10 million impact from the Calvert City outage. Outlook Whitaker announced, "we are narrowing our adjusted EBITDA range to $400 million to $420 million" for fiscal 2026. He noted, "Life Sciences and Personal Care remain resilient, supported by stable end markets and momentum across our globalize and Innovate platforms. Specialty Additives and Intermediates remain mixed with a coatings recovery expected to be gradual and regionally uneven." Management explained, "our revised outlook reflects approximately $11 million of temporary impacts from the Calvert City start-up delay and...

Earnings Call Insights: CorVel Corporation (CRVL) Q3 2026 Management View Michael Combs, President, CEO & Chairman, stated that the December quarter results were modest relative to expectations, primarily reflecting short-term operational factors rather than a change in fundamentals, citing normalization of the effective tax rate as a key factor. Combs highlighted that "the net revenue retention for business was 107%. We had a 44% close rate on new business opportunities, and we experienced strong incremental growth with existing partners." The company increased traction with AI initiatives, focusing on augmenting the development process, increasing operational efficiency, elevating the work of team members, and enhancing outcomes for partners. Combs provided detailed examples of AI integration in claims management, case management, and software development, aiming for "meaningful reductions in service delivery costs while simultaneously improving client outcomes." Combs discussed a technology-centric acquisition closed at the end of June, noting that "we're realizing meaningful increases in efficiency and effectiveness in the health payment integrity services for the Commercial Health segment through the integration of related logic and functionality through the acquisition." Brian Nichols, Chief Financial Officer, reported, "CorVel's revenue for the 9 months ending December 31, 2025, were $710 million, a 7% increase from $664 million at the same period of the previous fiscal year. Fiscal year-to-date earnings per share were $1.53, up 16% compared to $1.32 during the 9 months ending December 31, 2024. The December 2025 quarter ended with revenues at $236 million, 3% above the $228 million achieved in the December 2024 quarter. Earnings per share for the December 2025 quarter were $0.47, an increase of 2% over the same quarter of the prior year's EPS at $0.46." Nichols added, "the allocation of general and administrative expenses decreased from 9.7% to 9.6% and marg...

格隆汇2月4日｜诺和诺德(NVO.N)在美国上市的股票周二跌超13%。此前该公司意外发出警告，称其2026年的销售额将比预期下降得更为严重，原因是价格压力影响了其畅销的糖尿病和减肥药物在美国的销售情况。这家丹麦公司表示，预计2026年全年全球销售额将较2025年水平下降5%至13%（不包括汇率变动因素）。相比之下，2025年全年销售额增长了10%。该公司表示，由于包括Ozempic和Wegovy在内的药品价格下降，美国的销售额将会减少。他们指出，公司近期与特朗普政府达成协议以降低药品价格。这两款药的主要成分在除美国以外的某些国家也将失去专利独占权，这可能会为低价的仿制药竞争打开局面。这一前景的恶化对于这家曾经发展迅猛的公司来说，又是一则坏消息。该公司曾是减肥药物市场的开拓者。

格隆汇2月4日｜上海黄金交易所黄金T+D 2月3日（周二）晚盘收盘上涨2.78%报1105.1元/克； 上海黄金交易所白银T+D 2月3日（周二）晚盘收盘上涨5.67%报22100.0元/千克。

The U.S. electric vehicle (EV) market is expected to have a tougher 2026, with a forecast 15% contraction in annual passenger EV sales . Meanwhile, overall vehicle sales are projected to decline 2.4% to 16.9 million units. Data also shows that EV ownership among U.S. households slipped to 5% in 2025 from 6% in 2023, suggesting the early push into electric and hybrid vehicles may be losing speed. That slower backdrop is showing up in Tesla’s (TSLA) latest results. Revenue for the fourth quarter came in at $24.9 billion , down 3% year-over-year (YOY). Tesla also gave up its spot as the world’s largest EV maker to Chinese rival BYD (BYDDY), which sold 2.26 million EVs in 2025. Even with that weakness, Roth Capital Markets analyst Craig Irwin has a different view. After the Q4 2025 earnings release on Jan. 29, Irwin reiterated a “Buy” rating and maintained a $505 price target on TSLA stock, saying he "would be a buyer on any near-term share price weakness." His view is based on applying a 15 times revenue multiple to 2026 estimates, and the analyst frames Tesla as a large-cap name that trades like an emerging growth stock — where catalysts, not current auto sales, will be the main driver of valuation. Why would an analyst recommend buying Tesla when its core automotive business is contracting, profit is halving, and its market share is slipping to Chinese competitors? Let’s take a closer look. What Tesla’s Numbers Really Show Today, Tesla is more than an EV maker. It’s a clean energy company that designs and sells EVs, software, and battery storage, and it makes money from both hardware sales and recurring services. Over the past 52 weeks, TSLA stock is up by about 10% . Year-to-date (YTD), however, shares are down roughly 6%. Tesla trades at a forward price‑to‑earnings (P/E) multiple of about 248 times versus roughly 18 times for its broader sector. That premium is based on real results, even if they do not come in a straight line. In Q4 2025, Tesla delivered 418,227 v...

Why This Analyst Says Any Dip in Tesla Stock Is Worth Buying Yahoo Finance

The nomination of Kevin Warsh to lead the Federal Reserve will not derail the global “debasement trade,” as mounting public debt makes the monetization of U.S. fiscal deficits inevitable. Fiscal Reality Despite the “bone-jarring” Friday crash that saw silver plunge 26% and gold drop 9%, the fundamental drivers of the precious metals rally remain unchallenged. According to economist Robin Brooks, the market's search for safe havens is fueled by a fiscal trajectory that no single personnel change can fix. Don't Miss: “On a fundamental level, the nomination of Kevin Warsh changes nothing about any of this,” Brooks noted in his Substack post, pointing to a “reckless path” of fiscal policy. “Public debt is high and rising. This pushes up longer-term yields, which makes it inevitable that political pressure on the Fed to cut interest rates and cap longer-term yields will mount.” ‘Dovish’ Market Signal Treasury yields fell following the announcement, and futures prices moved to reflect additional rate cuts. This suggests that the market expects Warsh to be “dovish on interest rates,” a stance that provides a fundamental tailwind for hard assets. Brooks argues that the political reality of the incoming administration will dictate Fed policy more than individual ideology. “Indeed, the worst possible nightmare for Warsh must be to have Trump turn on him the way he turned on Powell. The only way to avoid this happening is to cut hard and fast ahead of the midterm elections.” Trending: Blue-chip art has historically outpaced the S&P 500 since 1995, and fractional investing is now opening this institutional asset class to everyday investors. Temporary Correction The recent volatility in silver and gold is being characterized as a “modest” setback rather than a trend reversal. Because the run-up in precious metals was so aggressive throughout January, the recent price drop only returned the metals to levels seen just a few weeks prior. “The debasement trade, which is markets sear...